Affini-T Therapeutics Completes $175 Million Financing Co-Led by Vida Ventures and Leaps by Bayer to Advance Groundbreaking T Cell Therapies for Solid Tumor Patients with Oncogenic Driver Mutations

Co-founded at Fred Hutchinson Cancer Research Center with Phil Greenberg, M.D., Aude Chapuis, M.D., and Tom Schmitt, Ph.D., and Vida Ventures along with serial entrepreneurs Arjun Goyal, M.D., M.Phil., and Jak Knowles, M.D./ Foundational cell therapy platform builds upon seminal work from co-founders, leveraging a T Cell Receptor (TCR) discovery en

Related Keywords

Phil Greenberg ,Arjun Goyal ,Aude Chapuis ,Tom Schmitt ,Fred Hutchinson Cancer Research Center ,Vida Ventures ,Jak Knowles ,Biotechnology ,Cancer ,Colorectal Cancer ,Disease ,Entrepreneurship ,Lung Cancer ,Pharmaceuticals ,Causes Of Death ,Clinical Medicine ,Skras ,Neoplasms ,Oncogenes ,Pancreatic Cancer ,Treatment Of Cancer ,Tumor Microenvironment ,